These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 35962458)

  • 1. Mesenchymal stem cells and their derived small extracellular vesicles for COVID-19 treatment.
    Huang Y; Li X; Yang L
    Stem Cell Res Ther; 2022 Aug; 13(1):410. PubMed ID: 35962458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment.
    Fang Y; Lao P; Tang L; Chen J; Chen Y; Sun L; Tan W; Fan X
    Cell Transplant; 2023; 32():9636897231184611. PubMed ID: 37395459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities.
    Moradinasab S; Pourbagheri-Sigaroodi A; Zafari P; Ghaffari SH; Bashash D
    Int Immunopharmacol; 2021 Aug; 97():107694. PubMed ID: 33932694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Curative Effect of Human Umbilical Cord-Derived Mesenchymal Stem Cells and Their Small Extracellular Vesicles in Treating Osteoarthritis.
    Tang S; Chen P; Zhang H; Weng H; Fang Z; Chen C; Peng G; Gao H; Hu K; Chen J; Chen L; Chen X
    Int J Nanomedicine; 2021; 16():8185-8202. PubMed ID: 34938076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia?
    Muraca M; Pessina A; Pozzobon M; Dominici M; Galderisi U; Lazzari L; Parolini O; Lucarelli E; Perilongo G; Baraldi E
    J Control Release; 2020 Sep; 325():135-140. PubMed ID: 32622963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stromal Cell-Based Therapy: A Promising Approach for Severe COVID-19.
    Xiong J; Chen L; Zhang L; Bao L; Shi Y
    Cell Transplant; 2021; 30():963689721995455. PubMed ID: 33650894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal Stem Cells in the Treatment of COVID-19, a Promising Future.
    Beghini DG; Horita SI; Henriques-Pons A
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19.
    Majolo F; da Silva GL; Vieira L; Timmers LFSM; Laufer S; Goettert MI
    Stem Cell Rev Rep; 2021 Feb; 17(1):44-55. PubMed ID: 32827081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cells as a Treatment Strategy for Coronavirus Disease 2019 (COVID-19): Need for Authority Regulations and Clinical Guidelines.
    Tufan AC
    Curr Stem Cell Res Ther; 2021; 16(4):465-480. PubMed ID: 33238848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications.
    Chen L; Qu J; Kalyani FS; Zhang Q; Fan L; Fang Y; Li Y; Xiang C
    Cell Mol Life Sci; 2022 Feb; 79(3):142. PubMed ID: 35187617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory Effects of Mesenchymal Stem Cells and their Secretomes in Pneumonia.
    Hezam K; Mo R; Wang C; Liu Y; Li Z
    Curr Pharm Biotechnol; 2022; 23(9):1153-1167. PubMed ID: 34493193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
    Al-Khawaga S; Abdelalim EM
    Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell-derived extracellular vesicles in therapy against fibrotic diseases.
    Huang Y; Yang L
    Stem Cell Res Ther; 2021 Aug; 12(1):435. PubMed ID: 34348793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cell treatment for COVID-19.
    Xu R; Feng Z; Wang FS
    EBioMedicine; 2022 Mar; 77():103920. PubMed ID: 35279630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Mesenchymal Stromal Cells-Derived Small Extracellular Vesicles in Diabetes and Its Chronic Complications.
    Li FX; Lin X; Xu F; Shan SK; Guo B; Lei LM; Zheng MH; Wang Y; Xu QS; Yuan LQ
    Front Endocrinol (Lausanne); 2021; 12():780974. PubMed ID: 34987478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Effectiveness of Intravascular Mesenchymal Stem Cells to Treat Organ Failure and Possible Application in COVID-19 Complications.
    Atluri S; Manocha V; Boddu N; Bhati S; Syed Z; Diwan S; Manchikanti L
    Pain Physician; 2020 Aug; 23(4S):S391-S420. PubMed ID: 32942796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment.
    O'Driscoll L
    Drug Discov Today; 2020 Jul; 25(7):1124-1125. PubMed ID: 32387262
    [No Abstract]   [Full Text] [Related]  

  • 18. Small Extracellular Vesicles Maintain Homeostasis of Senescent Mesenchymal Stem Cells at Least Through Excreting Harmful Lipids.
    Wang L; Zhang H; Xiao X; Wang S; Zhao RC
    Stem Cells Dev; 2023 Sep; 32(17-18):565-579. PubMed ID: 37262010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles as novel cell-free therapy for treatment of autoimmune disorders.
    Kahmini FR; Shahgaldi S
    Exp Mol Pathol; 2021 Feb; 118():104566. PubMed ID: 33160961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
    Atluri S; Manchikanti L; Hirsch JA
    Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.